MedPath

POMALIDOMIDA SANDOZ 4 MG CAPSULAS DURAS EFG

POMALIDOMIDA SANDOZ 4 MG CAPSULAS DURAS EFG

Commercialized
Register Number

89688

Prescription Type

Uso Hospitalario

Authorization Date

Aug 23, 2024

Dosage Form

CÁPSULA DURA

Route: VÍA ORAL

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number89688
EMA Approved
No

Drug Classification

Generic
Yes
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

POMALIDOMIDAActive
Quantity: 4 mg
Name: POMALIDOMIDA

ATC CLASSIFICATION (3)

L04A
L04AX
L04AX06

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.